Superior Graft-versus-Leukemia Effect Associated with Transplantation of Haploidentical Compared with HLA-Identical Sibling Donor Grafts for High-Risk Acute Leukemia: An Historic Comparison-Reference-Cited by-同舟云学术

Superior Graft-versus-Leukemia Effect Associated with Transplantation of Haploidentical Compared with HLA-Identical Sibling Donor Grafts for High-Risk Acute Leukemia: An Historic Comparison

Published:2011-06 Issue:6 Volume:17 Page:821-830
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Wang Yu,Liu Dai-Hong,Xu Lan-Ping,Liu Kai-Yan,Chen Huan,Chen Yu-Hong,Han Wei,Shi Hong-Xia,Huang Xiao-Jun

Funder

National Outstanding Young Scientist’s Foundation

Program for Innovative Research Team

Leading Program of Clinical Faculty

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference35 articles.

1. European experience of bone marrow transplantation for leukemia;Ringden;Transplant Proc,1987

2. Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000);Kanda;Blood,2003

3. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings;Szydlo;J Clin Oncol,1997

4. Marrow transplantation from related donors other than HLA-identical siblings;Beatty;N Engl J Med,1985

5. Use of partially mismatched related donors extends access to allogeneic marrow transplant;Henslee-Downey;Blood,1997

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hybrid allogeneic bone marrow transplant rescue approach after acute myelogenous leukaemia relapse in a high‐risk patient;British Journal of Haematology;2024-09-05

2. Advancing Allogeneic Hematopoietic Stem Cell Transplantation Outcomes through Immunotherapy: A Comprehensive Review of Optimizing Non-CAR Donor T-Lymphocyte Infusion Strategies;Biomedicines;2024-08-14

3. Haploidentical transplantation in primary refractory/relapsed secondary vs de novo AML: from the ALWP/EBMT;Blood Advances;2024-08-13

4. Reduced-toxicity conditioning regimen with low dose post-transplantation cyclophosphamide and low-dose anti-thymocyte globulin as graft-versus-host disease prophylaxis for haploidentical stem cell transplantation in older patients;Annals of Hematology;2024-05-29

5. Current status of conditioning regimens in haploidentical hematopoietic cell transplantation;Hematology;2024-03-21